88 related articles for article (PubMed ID: 21768671)
1. Association and treatment response to capecitabine-based chemoradiotherapy with CYP2C9 polymorphism in head and neck cancer.
Paul S; Pant MC; Parmar D; Verma J
Indian J Cancer; 2011; 48(2):223-9. PubMed ID: 21768671
[TBL] [Abstract][Full Text] [Related]
2. Association of poor metabolizers of cytochrome P450 2C19 with head and neck cancer and poor treatment response.
Yadav SS; Ruwali M; Shah PP; Mathur N; Singh RL; Pant MC; Parmar D
Mutat Res; 2008 Sep; 644(1-2):31-7. PubMed ID: 18644391
[TBL] [Abstract][Full Text] [Related]
3. Association of cytochrome P450 2C9 polymorphism with locally advanced head and neck squamous cell carcinoma and response to concurrent cisplatin-based radical chemoradiation.
Paul S; Chaudhuri T; Pant MC; Parmar D; Srivastava K
South Asian J Cancer; 2014 Jul; 3(3):154-8. PubMed ID: 25136521
[TBL] [Abstract][Full Text] [Related]
4. Interaction of drug metabolizing cytochrome P450 2D6 poor metabolizers with cytochrome P450 2C9 and 2C19 genotypes modify the susceptibility to head and neck cancer and treatment response.
Yadav SS; Ruwali M; Pant MC; Shukla P; Singh RL; Parmar D
Mutat Res; 2010 Feb; 684(1-2):49-55. PubMed ID: 19954746
[TBL] [Abstract][Full Text] [Related]
5. Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer.
Singh M; Shah PP; Singh AP; Ruwali M; Mathur N; Pant MC; Parmar D
Mutat Res; 2008 Feb; 638(1-2):184-94. PubMed ID: 18035380
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 2E1 and head and neck cancer: interaction with genetic and environmental risk factors.
Ruwali M; Khan AJ; Shah PP; Singh AP; Pant MC; Parmar D
Environ Mol Mutagen; 2009 Jul; 50(6):473-82. PubMed ID: 19334053
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism in cytochrome P450 2A6 and glutathione S-transferase P1 modifies head and neck cancer risk and treatment outcome.
Ruwali M; Pant MC; Shah PP; Mishra BN; Parmar D
Mutat Res; 2009 Oct; 669(1-2):36-41. PubMed ID: 19406142
[TBL] [Abstract][Full Text] [Related]
8. CYP 2D6 polymorphism: a predictor of susceptibility and response to chemoradiotherapy in head and neck cancer.
Shukla P; Gupta D; Pant MC; Parmar D
J Cancer Res Ther; 2012; 8(1):40-5. PubMed ID: 22531512
[TBL] [Abstract][Full Text] [Related]
9. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.
Quintela-Fandino M; Hitt R; Medina PP; Gamarra S; Manso L; Cortes-Funes H; Sanchez-Cespedes M
J Clin Oncol; 2006 Sep; 24(26):4333-9. PubMed ID: 16896002
[TBL] [Abstract][Full Text] [Related]
10. Clinical results of definitive chemoradiotherapy for patients with synchronous head and neck squamous cell carcinoma and esophageal cancer.
Shinoto M; Shioyama Y; Sasaki T; Nakamura K; Ohura H; Toh Y; Higaki Y; Yamaguchi T; Ohnishi K; Atsumi K; Hirata H; Honda H
Am J Clin Oncol; 2011 Aug; 34(4):362-6. PubMed ID: 20686402
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
[TBL] [Abstract][Full Text] [Related]
12. Association of polymorphism in cytochrome P450 2C9 with susceptibility to head and neck cancer and treatment outcome.
Yadav SS; Seth S; Khan AJ; Maurya SS; Dhawan A; Pant S; Pant MC; Parmar D
Appl Transl Genom; 2014 Mar; 3(1):8-13. PubMed ID: 27275407
[TBL] [Abstract][Full Text] [Related]
13. Association between transforming growth factor beta1 genetic polymorphism and response to chemoradiotherapy in head and neck squamous cell cancer.
Lundberg M; Pajusto M; Koskinen WJ; Mäkitie AA; Aaltonen LM; Mattila PS
Head Neck; 2009 May; 31(5):664-72. PubMed ID: 19260117
[TBL] [Abstract][Full Text] [Related]
14. Single-nucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption.
Werbrouck J; De Ruyck K; Duprez F; Van Eijkeren M; Rietzschel E; Bekaert S; Vral A; De Neve W; Thierens H
Mutat Res; 2008 Oct; 656(1-2):74-81. PubMed ID: 18768166
[TBL] [Abstract][Full Text] [Related]
15. The ADH1C polymorphism modifies the risk of squamous cell carcinoma of the head and neck associated with alcohol and tobacco use.
Peters ES; McClean MD; Liu M; Eisen EA; Mueller N; Kelsey KT
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):476-82. PubMed ID: 15734975
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of the epidermal growth factor receptor (EGFR) and survival in patients with advanced cancer of the head and neck (HNSCC).
Stoehlmacher-Williams J; Obermann L; Ehninger G; Goekkurt E
Anticancer Res; 2012 Feb; 32(2):421-5. PubMed ID: 22287728
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.
Gautschi O; Hugli B; Ziegler A; Bigosch C; Bowers NL; Ratschiller D; Jermann M; Stahel RA; Heighway J; Betticher DC
Lung Cancer; 2006 Mar; 51(3):303-11. PubMed ID: 16406195
[TBL] [Abstract][Full Text] [Related]
18. Association between the V109G polymorphism of the p27 gene and the risk and progression of oral squamous cell carcinoma.
Li G; Sturgis EM; Wang LE; Chamberlain RM; Spitz MR; El-Naggar AK; Hong WK; Wei Q
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3996-4002. PubMed ID: 15217930
[TBL] [Abstract][Full Text] [Related]
19. DNA repair gene excision repair cross complementing-group 1 (ERCC1) in head and neck squamous cell carcinoma: analysis of methylation and polymorphism (G19007A), protein expression and association with epidemiological and clinicopathological factors.
Lima LM; de Souza LR; da Silva TF; Pereira CS; Guimarães AL; de Paula AM; de Andrade Carvalho H
Histopathology; 2012 Feb; 60(3):489-96. PubMed ID: 22176134
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms in cytochrome P4501B1 and susceptibility to head and neck cancer.
Singh AP; Shah PP; Mathur N; Buters JT; Pant MC; Parmar D
Mutat Res; 2008 Mar; 639(1-2):11-9. PubMed ID: 18067928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
